跳至主要内容
临床试验/DRKS00021041
DRKS00021041招募中不适用

Working party multiple myeloma - OSHO registry of myeloma - OSH #89

niversitätsklinikum Rostock0 个研究点目标入组 2,500 人开始时间: 2020年3月26日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
2,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • 1. Patients with multiple myeloma (including extraosseous plasmocytoma, solitary plasmocytoma of the bone, smouldering myeloma).
  • a. At the time of the initial diagnosis in patients with myeloma requiring treatment or multiple myeloma requiring treatment
  • b. At the time of a change in therapy in patients with multiple myeloma requiring treatment
  • 2. Presence of a declaration of consent

排除标准

  • 1. Non-consenting patients
  • 2. Simultaneous participation of patients in another myeloma registry supported by the participating pharmaceutical companies
  • 3. Diagnosis of a monoclonal gammopathy of unclear significance

研究者

发起方
niversitätsklinikum Rostock

相似试验

Working party multiple myeloma - OSHO registry of... | 临床试验